Lubiński K (2026). [PMID: 41828619](https://pubmed.ncbi.nlm.nih.gov/41828619/). *Int J Mol Sci*. [Epidemiology / Natural History]
Alenezi WM (2026). [PMID: 41596682](https://pubmed.ncbi.nlm.nih.gov/41596682/). *Int J Mol Sci*. [Basic Science / Preclinical]
McNamara N (2026). [PMID: 41765746](https://pubmed.ncbi.nlm.nih.gov/41765746/). *Semin Oncol Nurs*. [Review / Meta-Analysis]
Choi SH (2026). [PMID: 41846317](https://pubmed.ncbi.nlm.nih.gov/41846317/). *HGG Adv*. [Diagnostic / Biomarker]
Alloubani A (2026). [PMID: 41207815](https://pubmed.ncbi.nlm.nih.gov/41207815/). *Semin Oncol Nurs*. [Review / Meta-Analysis]
Dejaegher K (2025). [PMID: 40504267](https://pubmed.ncbi.nlm.nih.gov/40504267/). *Fam Cancer*. [Epidemiology / Natural History]
Cabello AERDS (2025). [PMID: 40544077](https://pubmed.ncbi.nlm.nih.gov/40544077/). *Clin Breast Cancer*. [Epidemiology / Natural History]
Aguilar D (2025). [PMID: 39815370](https://pubmed.ncbi.nlm.nih.gov/39815370/). *Breast Cancer Res*. [Basic Science / Preclinical]
Wiese J (2025). [PMID: 40974220](https://pubmed.ncbi.nlm.nih.gov/40974220/). *J Investig Med High Impact Case Rep*. [Case Report / Case Series]
Osler TS (2025). [PMID: 39776011](https://pubmed.ncbi.nlm.nih.gov/39776011/). *Breast Cancer Res Treat*. [Diagnostic / Biomarker]
